Prognostic significance of BCL-2 expression in triple negative breast cancer (TNBC)

被引：0
|
作者：
Srinivasalu, V. K. [1 ,2 ]
Susan, A. [3 ]
Jose, W. M. [4 ]
Philip, A. [5 ]
Nambiar, A. [6 ]
Pavithran, K. [5 ]
机构：
[1] Mazumdar Shaw Canc Ctr, Med Oncol & Hematol, Bangalore, Karnataka, India
[2] Narayana Hrudayalaya, Bangalore, Karnataka, India
[3] Lakeshore Hosp, Med Oncol, Kochi, Kerala, India
[4] Amrita Inst Med Sci, Inst Canc, Med Oncol & Hematol, Kochi, Kerala, India
[5] Amrita Inst Med Sci, Med Oncol, Kochi, Kerala, India
[6] Amrita Inst Med Sci, Pathol, Kochi, Kerala, India
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
41P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Correlation between bcl-2 expression and prognostic factors of breast cancer
    Gwak, G.
    Park, K.
    Han, S.
    Park, S.
    Cho, H.
    Yang, K.
    Bae, B.
    Kim, K.
    Kim, H.
    Kim, Y.
    Kim, H.
    Kim, K.
    BREAST, 2009, 18 : S27 - S27
  • [22] Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
    Minghui Zhang
    Xiaosan Zhang
    Shu Zhao
    Yan Wang
    Wenyu Di
    Gangling Zhao
    Maopeng Yang
    Qingyuan Zhang
    Targeted Oncology, 2014, 9 : 349 - 357
  • [23] Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients
    Kapranos, N
    Karaiosifidi, H
    Valavanis, C
    Kouri, ES
    Vasilaros, S
    ANTICANCER RESEARCH, 1997, 17 (4A) : 2499 - 2505
  • [24] Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus
    Y-L Zhai
    T Nikaido
    T Toki
    A Shiozawa
    A Orii
    S Fujii
    British Journal of Cancer, 1999, 80 : 1658 - 1664
  • [25] Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus
    Zhai, YL
    Nikaido, T
    Toki, T
    Shiozawa, A
    Orii, A
    Fujii, S
    BRITISH JOURNAL OF CANCER, 1999, 80 (10) : 1658 - 1664
  • [26] The prognostic significance of TILs as a biomarker in triple-negative breast cancer: what is the role of TILs in TME of TNBC?
    Zhou, Y.
    Tian, Q.
    Wang, B-Y
    Yang, J.
    Zhao, S-D
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (07) : 2885 - 2897
  • [27] Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
    Zhang, Minghui
    Zhang, Xiaosan
    Zhao, Shu
    Wang, Yan
    Di, Wenyu
    Zhao, Gangling
    Yang, Maopeng
    Zhang, Qingyuan
    TARGETED ONCOLOGY, 2014, 9 (04) : 349 - 357
  • [28] Prognostic value of Bcl-2 in breast cancer
    Ibeas, Patricia
    Lopez-Gonzalez, Ana
    Gaston Doger de Speville, Bernard
    Huelves, Miriam
    Lopez, Roberto
    Almagro, Elena
    Palka, Magda
    Ruiz-Valdepenas, Andrea
    Perez Callejo, David
    Provencio, Mariano
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Glucocorticoid actions in triple negative breast cancer (TNBC) and its clinical significance
    Kumata, Rina
    McNamara, Keely M.
    Kanai, Ayako
    Onodera, Yoshiaki
    Kikuchi, Kyoko
    Miyashita, Minoru
    Sagara, Yasuaki
    Rai, Yoshiaki
    Ohi, Yasuyo
    Yamaguchi, Rin
    Ishida, Takanori
    Ofuchi, Noriaki
    Sasano, Hironobu
    CANCER SCIENCE, 2018, 109 : 661 - 661
  • [30] Expression and activation of protein kinases in Triple Negative Breast Cancer (TNBC)
    Walsh, S.
    Pierce, A.
    Flanagan, L.
    O'Donovan, N.
    Quinn, C.
    Evoy, D.
    McDermott, E.
    Duffy, M. J.
    EJC SUPPLEMENTS, 2010, 8 (03): : 90 - 90
12345